Leadership Team

David A. Haake

Chief Medical Officer


Click to read more

Susan Novak-Weekley

V.P. of Medical Affairs


Click to read more

Tino Alavie

President & CEO


Click to read more

Richard Brock

V.P. of Global Marketing


Click to read more

Mary-Kay Lippert

V.P. of Manufacturing Operations


Click to read more

Aye Aye Khine

Principal Scientist


Click to read more

Michael Fricker

Chief Financial Officer


Click to read more

Samad Talebpour

Chief Scientist


Click to read more

Herbert Torfs

V.P. of Business Development EMEA


Click to read more

Glenn Magnuson

V.P. of North American Sales


Click to read more

Robert Maaskant

V.P. of Product Development


Click to read more

Stephen Leonard

Head of Intellectual Property


Click to read more

Join Us

Qvella's Field Activated Sample Treatment (FAST™) technology

Qvella was founded with a vision to enable faster clinical decisions for better patient outcomes in sepsis diagnosis by reducing time to actionable results. Qvella’s FAST-Technology™ (Field Activated Sample Treatment) facilitates automation and acceleration of different stages of microbiology workflow to generate actionable information for bloodstream infections in minutes.

Know More